In a Phase III randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day-to-day function when compared with whole brain…
Continue Reading
News Source: medicalxpress.com
Leave a Reply